Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
DR Blystad AS
AS
Active
Org 913884477
Bulls Gate 2B, 3110
Tønsberg
General medical practice activities
·
NACE 8621
Est. 2014 · 12 years old
3 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
DR Blystad AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
7M
6M
4M
2M
0M
2021: 4M
4M
2021
2022: 5M (+25% vs 2021)
5M
+25%
2022
2023: 5M (0% vs 2022)
5M
0%
2023
2024: 5M (0% vs 2023)
5M
0%
2024
2025: 6M (+20% vs 2024)
6M
+20%
2025
EBITDA
NOK millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 3M (+200% vs 2021)
3M
+200%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: 2M (-33% vs 2023)
2M
-33%
2024
2025: 3M (+50% vs 2024)
3M
+50%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
5 515
5 302
5 259
4 908
4 159
Staff expenses
−1 780
−1 847
−1 703
−1 469
−1 060
EBITDA
2 682
2 449
2 628
2 561
1 476
Depreciation & amort.
−8
−15
−59
−70
−61
EBIT
2 674
2 434
2 569
2 491
1 415
Net financials
69
113
−8
−142
−49
Profit before tax
2 742
2 547
2 560
2 349
1 366
Tax
582
534
562
534
303
Net profit
2 160
2 013
1 999
1 815
1 063
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
6 116
5 284
5 255
4 319
3 352
Equity
2 947
2 434
2 771
1 482
1 277
Long-term debt
0
1 175
1 265
1 356
1 446
Short-term debt
2 058
1 676
1 219
1 481
629
Total debt
3 169
2 851
2 484
2 837
2 075
Financial ratios
5-year trend
EBITDA margin
48,6 %
This company
15,8 %
Market median
This company
Market median
208% above market
2021
2025
Equity ratio
48,2 %
This company
38,2 %
Market median
This company
Market median
26% above market
2021
2025
Return on equity
73,3 %
This company
18,4 %
Market median
This company
Market median
298% above market
2021
2025
Net profit margin
39,2 %
This company
8,1 %
Market median
This company
Market median
384% above market
2021
2025
Asset turnover
0,90×
This company
1,12×
Market median
This company
Market median
20% below market
2021
2025
Debt / equity
1,08×
This company
0,62×
Market median
This company
Market median
74% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on DR Blystad AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
